prakash bhuyan

Employment

• Aerium Therapeutics Chief Medical Officer
• Inovio Pharmaceuticals (United States)
• University of Pennsylvania Perelman School of Medicine
• Merck and Co Inc West Point
• Pfizer Global Research and Development

Education

• University of Texas Southwestern Medical School
• University of Pennsylvania Perelman School of Medicine
• Johns Hopkins University
• Emory University School of Medicine

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
  Human Vaccines and Immunotherapeutics 2020 DOI: 10.1080/21645515.2019.1695459
  +Save
• Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
  Human Vaccines and Immunotherapeutics 2020 DOI: 10.1080/21645515.2020.1823778
  +Save
• A phase 2, randomized, active-controlled, observer-blinded study to assess the immunogenicity, tolerability and safety of bivalent rLP2086, a meningococcal serogroup b vaccine, coadministered with tetanus, diphtheria and acellular pertussis vaccine and s…
  Pediatric Infectious Disease Journal 2016 DOI: 10.1097/INF.0000000000001124
  +Save
• Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine
  Pediatric Infectious Disease Journal 2016 DOI: 10.1097/INF.0000000000001072
  +Save
• Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers
  Vaccine 2016 DOI: 10.1016/j.vaccine.2015.12.016
  +Save
• Repurposing historical control clinical trial data to provide safety context
  Drug Discovery Today 2016 DOI: 10.1016/j.drudis.2015.10.018
  +Save
• Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients
  Vaccine 2014 DOI: 10.1016/j.vaccine.2014.09.015
  +Save
• Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits wi…
  Pediatric Infectious Disease Journal 2014 DOI: 10.1097/01.inf.0000437806.76221.20
  +Save
• Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: A randomized, open-label study
  Pediatric Infectious Disease Journal 2013 DOI: 10.1097/INF.0b013e3182717edf
  +Save
• Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates
  Vaccine 2012 DOI: 10.1016/j.vaccine.2011.12.095
  +Save